0001209191-23-047104.txt : 20230823
0001209191-23-047104.hdr.sgml : 20230823
20230823175901
ACCESSION NUMBER: 0001209191-23-047104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230821
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harford Simon N.R.
CENTRAL INDEX KEY: 0001443705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 231198501
MAIL ADDRESS:
STREET 1: AVON PRODUCTS, INC.
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 921-7600
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-21
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001443705
Harford Simon N.R.
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET
PHILADELPHIA
PA
19104
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-08-21
4
A
0
106973
0.00
A
106973
D
Stock Options (right to buy)
12.62
2023-08-21
4
A
0
189043
0.00
A
2033-08-21
Common Stock
189043
189043
D
Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on August 21, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.
/s/ Christian Formica, Attorney-in-Fact
2023-08-23